ENDRA Operating Cycle from 2010 to 2026

NDRA Stock  USD 4.00  0.56  12.28%   
ENDRA Life's Operating Cycle is increasing over the years with slightly volatile fluctuation. Overall, Operating Cycle is expected to go to 3,894 this year. From 2010 to 2026 ENDRA Life Operating Cycle quarterly data regression line had arithmetic mean of  1,546 and r-squared of  0.73. View All Fundamentals
 
Operating Cycle  
First Reported
2010-12-31
Previous Quarter
3.7 K
Current Value
3.9 K
Quarterly Volatility
1.7 K
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check ENDRA Life financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ENDRA Life's main balance sheet or income statement drivers, such as Depreciation And Amortization of 50.8 K, Interest Expense of 23.5 K or Selling General Administrative of 4.1 M, as well as many indicators such as Price To Sales Ratio of 1.8 M, Dividend Yield of 7.0E-4 or PTB Ratio of 3.0. ENDRA financial statements analysis is a perfect complement when working with ENDRA Life Valuation or Volatility modules.
  
Build AI portfolio with ENDRA Stock
Check out the analysis of ENDRA Life Correlation against competitors.

Latest ENDRA Life's Operating Cycle Growth Pattern

Below is the plot of the Operating Cycle of ENDRA Life Sciences over the last few years. It is ENDRA Life's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ENDRA Life's overall financial position and show how it may be relating to other accounts over time.
Operating Cycle10 Years Trend
Slightly volatile
   Operating Cycle   
       Timeline  

ENDRA Operating Cycle Regression Statistics

Arithmetic Mean1,546
Geometric Mean696.50
Coefficient Of Variation109.97
Mean Deviation1,503
Median360.02
Standard Deviation1,701
Sample Variance2.9M
Range4.1K
R-Value0.85
Mean Square Error834,302
R-Squared0.73
Significance0.000013
Slope287.65
Total Sum of Squares46.3M

ENDRA Operating Cycle History

2026 3894.12
2025 3708.69
2022 4120.76
2021 2089.3
2020 1302.35
2018 360.02
2017 412.03

About ENDRA Life Financial Statements

ENDRA Life stakeholders use historical fundamental indicators, such as ENDRA Life's Operating Cycle, to determine how well the company is positioned to perform in the future. Although ENDRA Life investors may analyze each financial statement separately, they are all interrelated. For example, changes in ENDRA Life's assets and liabilities are reflected in the revenues and expenses on ENDRA Life's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in ENDRA Life Sciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Operating Cycle3.7 K3.9 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether ENDRA Life Sciences offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ENDRA Life's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Endra Life Sciences Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Endra Life Sciences Stock:
Check out the analysis of ENDRA Life Correlation against competitors.
You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ENDRA Life. Anticipated expansion of ENDRA directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive ENDRA Life assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
19.52
Return On Assets
(1.02)
Return On Equity
(2.36)
Understanding ENDRA Life Sciences requires distinguishing between market price and book value, where the latter reflects ENDRA's accounting equity. The concept of intrinsic value—what ENDRA Life's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push ENDRA Life's price substantially above or below its fundamental value.
It's important to distinguish between ENDRA Life's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ENDRA Life should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, ENDRA Life's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.